266 related articles for article (PubMed ID: 11813154)
1. Head and neck brachytherapy.
Mazeron JJ; Noël G; Simon JM
Semin Radiat Oncol; 2002 Jan; 12(1):95-108. PubMed ID: 11813154
[TBL] [Abstract][Full Text] [Related]
2. [Brachytherapy of head and neck cancer].
Takácsi Nagy Z; Kásler M
Magy Onkol; 2008 Jun; 52(2):145-50. PubMed ID: 18640890
[TBL] [Abstract][Full Text] [Related]
3. [Brachytherapy in head and neck cancers].
Mazeron JJ; Noël G; Simon JM; Racadot S; Jauffret E
Cancer Radiother; 2003 Feb; 7(1):62-72. PubMed ID: 12648718
[TBL] [Abstract][Full Text] [Related]
4. Treatment of oral cavity and oropharyngeal cancer. Indications, technical aspects, and results of interstitial brachytherapy.
Strnad V
Strahlenther Onkol; 2004 Nov; 180(11):710-7. PubMed ID: 15549189
[TBL] [Abstract][Full Text] [Related]
5. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
[TBL] [Abstract][Full Text] [Related]
6. [ORL brachytherapy. Salvage brachytherapy in ORL cancers (oral cavity, oropharynx, nasopharynx)].
Ardiet JM; Coquard R; Peiffert D; Montbarbon X; Pernot M; Gérard JP
Bull Cancer Radiother; 1995; 82(2):199-202. PubMed ID: 7546891
[No Abstract] [Full Text] [Related]
7. Late effects of post-high-dose-rate brachytherapy for oropharyngeal carcinoma: are they severer than post-low-dose-rate?
Nose T; Peiffert D; Lapeyre M; Hoffstetter S; Koizumi M; Nishiyama K
Strahlenther Onkol; 2004 Dec; 180(12):776-82. PubMed ID: 15592697
[TBL] [Abstract][Full Text] [Related]
8. Role of interstitial PDR brachytherapy in the treatment of oral and oropharyngeal cancer. A single-institute experience of 236 patients.
Strnad V; Melzner W; Geiger M; Zenk J; Waldfahrer F; Lotter M; Ott O; Seeger A; Iro H; Sauer R
Strahlenther Onkol; 2005 Dec; 181(12):762-7. PubMed ID: 16362785
[TBL] [Abstract][Full Text] [Related]
9. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.
King CR
Brachytherapy; 2002; 1(4):219-26. PubMed ID: 15062170
[TBL] [Abstract][Full Text] [Related]
10. [Brachytherapy for head and neck cancers (nasopharynx excluded)].
Lapeyre M; Bellière A; Hoffstetter S; Peiffert D
Cancer Radiother; 2008 Nov; 12(6-7):515-21. PubMed ID: 18824384
[TBL] [Abstract][Full Text] [Related]
11. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
12. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer.
Glatzel M; Büntzel J; Schröder D; Küttner K; Fröhlich D
Laryngoscope; 2002 Aug; 112(8 Pt 1):1366-71. PubMed ID: 12172246
[TBL] [Abstract][Full Text] [Related]
13. Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity?
Melzner WJ; Lotter M; Sauer R; Strnad V
Radiother Oncol; 2007 Feb; 82(2):167-73. PubMed ID: 17258340
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate interstitial brachytherapy for oropharyngeal carcinoma: results of 83 lesions in 82 patients.
Nose T; Koizumi M; Nishiyama K
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):983-91. PubMed ID: 15234031
[TBL] [Abstract][Full Text] [Related]
15. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas.
Mazeron JJ; Ardiet JM; Haie-Méder C; Kovács G; Levendag P; Peiffert D; Polo A; Rovirosa A; Strnad V
Radiother Oncol; 2009 May; 91(2):150-6. PubMed ID: 19329209
[TBL] [Abstract][Full Text] [Related]
16. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
[TBL] [Abstract][Full Text] [Related]
17. Interstitial brachytherapy as boost for locally advanced T4 head and neck cancer.
Do L; Puthawala A; Syed N
Brachytherapy; 2009; 8(4):385-91. PubMed ID: 19733128
[TBL] [Abstract][Full Text] [Related]
18. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
[TBL] [Abstract][Full Text] [Related]
19. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
[TBL] [Abstract][Full Text] [Related]
20. High dose rate brachytherapy in the treatment of oral cancer--the preliminary one institution experience.
Petera J; Dolezel M; Jirousek Z; Tucek L; Bedrosová J; Frgala T
Neoplasma; 2006; 53(3):232-6. PubMed ID: 16652193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
